After the main material follow three appendices in the British edition, the first explaining the title ( as mentioned above ) and two accounts of Burroughs'own drug abuse and treatment using apomorphine.
42.
It has been reported that centrally-acting NK 1 receptors antagonists, such as CP-99994, inhibit emesis induced by apomorphine and loperimidine, which are two compounds that act through central mechanisms.
43.
After an initial " apomorphine challenge " in hospital to test its effectiveness and brief patient and primary caregiver ( often a spouse or partner ), the latter of whom takes over maintenance of the pump.
44.
Richard Kattau in the Rathbun laboratory tested the newly created drugs within the series of PPAs for their ability to reverse apomorphine-induced hypothermia in mice, a test in which the TCAs were active antagonists.
45.
The protective effects of apomorphine were tested in mouse models with mutations in genes related to AD, such as the amyloid precursor protein ( APP ) gene, which is implicated in amyloid molecule build-up.
46.
Cynapsus lead drug candidate, APL-130277, is an easy-to-administer, fast-acting and oral reformulation of an approved drug, apomorphine, used to rescue patients from off episodes.
47.
Following a successful apomorphine challenge, training of patient and caregiver, and careful dose titration, the patient can be maintained in the " on " state by the use of an apomorphine pump as an effective monotherapy.
48.
Following a successful apomorphine challenge, training of patient and caregiver, and careful dose titration, the patient can be maintained in the " on " state by the use of an apomorphine pump as an effective monotherapy.
49.
In 1983, she had been in an experiment in which investigators withdrew her medication, did nothing as she became increasingly manic, and then injected her with apomorphine, a chemical that other researchers suspected could provoke psychosis.
50.
The FTC had balked about the overlap in the companies'drug portfolios, spurring Peapack, New Jersey-based Pharmacia to agree to return experimental impotence drug apomorphine to its developer, Nastech Pharmaceuticals, for $ 13.5 million.
